tiprankstipranks
Immix Biopharma Shareholders Back Growth and Governance Changes
PremiumCompany AnnouncementsImmix Biopharma Shareholders Back Growth and Governance Changes
5M ago
Immix Biopharma announces NXC-201 relapsed/refractory AL Amyloidosis data
Premium
The Fly
Immix Biopharma announces NXC-201 relapsed/refractory AL Amyloidosis data
7M ago
Immix Biopharma management to meet with B. Riley
Premium
The Fly
Immix Biopharma management to meet with B. Riley
7M ago
Immix Biopharma: EC grants orphan drug designation to NXC-201
PremiumThe FlyImmix Biopharma: EC grants orphan drug designation to NXC-201
10M ago
Immix Biopharma Announces New Offering, Sparks Investor Interest
Premium
Company Announcements
Immix Biopharma Announces New Offering, Sparks Investor Interest
10M ago
Immix Biopharma Signs Definitive $15M Titan Partnership Deal
Premium
Company Announcements
Immix Biopharma Signs Definitive $15M Titan Partnership Deal
10M ago
Three new option listings on January 24th
PremiumThe FlyThree new option listings on January 24th
10M ago
Immix Biopharma reports 100% ORR for CAR-T NXC-201 in r/r AL amyloidosis
Premium
The Fly
Immix Biopharma reports 100% ORR for CAR-T NXC-201 in r/r AL amyloidosis
12M ago
Immix Biopharma to hold virtual investor day
Premium
The Fly
Immix Biopharma to hold virtual investor day
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100